TANDEM DIABETES CARE INC (TNDM) Stock Price, Quote, News and Overview
NASDAQ:TNDM - Nasdaq - US8753722037 - Common Stock - Currency: USD
TNDM Quote, Performance and Key Statistics
16.85
+0.08 (+0.48%)
The current stock price of TNDM is 16.85 USD. In the past month the price decreased by -10.04%. In the past year, price decreased by -62.32%.
TNDM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.35 | 226.76B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.51 | 184.80B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.1 | 152.15B | ||
| SYK | STRYKER CORP | 30.67 | 142.72B | ||
| MDT | MEDTRONIC PLC | 15.87 | 108.71B | ||
| BDX | BECTON DICKINSON AND CO | 14.89 | 59.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.03 | 44.38B | ||
| IDXX | IDEXX LABORATORIES INC | 38.46 | 35.06B | ||
| RMD | RESMED INC | 26.06 | 34.75B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.66 | 32.20B | ||
| DXCM | DEXCOM INC | 43.26 | 27.99B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.04 | 23.83B |
Related stock screener links
About TNDM
Company Profile
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Company Info
TANDEM DIABETES CARE INC
12400 High Bluff Drive
San Diego CALIFORNIA 92121 US
CEO: John F. Sheridan
Employees: 2400
Company Website: https://www.tandemdiabetes.com/
Investor Relations: https://investor.tandemdiabetes.com/
Phone: 18583666900
TANDEM DIABETES CARE INC / TNDM FAQ
What is the stock price of TANDEM DIABETES CARE INC today?
The current stock price of TNDM is 16.85 USD. The price increased by 0.48% in the last trading session.
What is the ticker symbol for TANDEM DIABETES CARE INC stock?
The exchange symbol of TANDEM DIABETES CARE INC is TNDM and it is listed on the Nasdaq exchange.
On which exchange is TNDM stock listed?
TNDM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TANDEM DIABETES CARE INC stock?
29 analysts have analysed TNDM and the average price target is 40.51 USD. This implies a price increase of 140.41% is expected in the next year compared to the current price of 16.85. Check the TANDEM DIABETES CARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TANDEM DIABETES CARE INC worth?
TANDEM DIABETES CARE INC (TNDM) has a market capitalization of 1.12B USD. This makes TNDM a Small Cap stock.
How many employees does TANDEM DIABETES CARE INC have?
TANDEM DIABETES CARE INC (TNDM) currently has 2400 employees.
What are the support and resistance levels for TANDEM DIABETES CARE INC (TNDM) stock?
TANDEM DIABETES CARE INC (TNDM) has a support level at 16.84 and a resistance level at 16.92. Check the full technical report for a detailed analysis of TNDM support and resistance levels.
Is TANDEM DIABETES CARE INC (TNDM) expected to grow?
The Revenue of TANDEM DIABETES CARE INC (TNDM) is expected to grow by 10% in the next year. Check the estimates tab for more information on the TNDM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TANDEM DIABETES CARE INC (TNDM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TNDM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TNDM, evaluating the profitability, health, valuation and growth aspects
- TANDEM DIABETES CARE INC (TNDM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TANDEM DIABETES CARE INC (TNDM) Sales and EPS estimates to see what analysts future expectations are.
- TANDEM DIABETES CARE INC (TNDM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TANDEM DIABETES CARE INC (TNDM) Insider and Institutional Ownership to learn about the owners and their transactions.
- TANDEM DIABETES CARE INC (TNDM) Stock Chart to make your own analysis
- TANDEM DIABETES CARE INC (TNDM) Latest news and press-releases to stay up to date.
Does TANDEM DIABETES CARE INC (TNDM) stock pay dividends?
TNDM does not pay a dividend.
When does TANDEM DIABETES CARE INC (TNDM) report earnings?
TANDEM DIABETES CARE INC (TNDM) will report earnings on 2025-04-30, after the market close.
What is the Price/Earnings (PE) ratio of TANDEM DIABETES CARE INC (TNDM)?
TANDEM DIABETES CARE INC (TNDM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.45).
What is the Short Interest ratio of TANDEM DIABETES CARE INC (TNDM) stock?
The outstanding short interest for TANDEM DIABETES CARE INC (TNDM) is 9.67% of its float. Check the ownership tab for more information on the TNDM short interest.
TNDM Technical Analysis
TNDM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TNDM. Both the profitability and financial health of TNDM have multiple concerns.
TNDM Financial Highlights
Over the last trailing twelve months TNDM reported a non-GAAP Earnings per Share(EPS) of -1.45. The EPS increased by 53.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.92% | ||
| ROE | -36.5% | ||
| Debt/Equity | 1.17 |
TNDM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to TNDM. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of 12.09% and a revenue growth 10% for TNDM